// App-Quantinova.ai

4605.0 : Risk of cancer-specific death for patients diagnosed with neuroendocrine tumors: A population-based analysis.

Researchers

Presenter

  • Julie Hallet

Principal Investigators

  • Calvin Law

  • Simron Singh

  • Alyson Mahar

  • Sten Myrehaug

  • Victoria Zuk

  • Haoyu Zhao

  • Angela Assal

  • Natalie Coburn

Medical Centers

  • Sunnybrook Odette Cancer Centre, Toronto, ON, Canada

  • Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada

  • Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada

  • Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada

  • Sunnybrook Health Sciences Centre, Toronto, ON, Canada

  • Sunnybrook Research Institute, Toronto, ON, Canada

  • OICR, Toronto, ON, Canada

  • HOPE Research Centre, Sunnybrook Hospital, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved